Literature DB >> 319991

Anthelmintics.

M Katz.   

Abstract

This article describes the drugs used in helminthic infections and their therapeutic indications, mode of action, toxicity and other details of each of the recommended drugs, and discusses the nature and treatment of infection by helminths important in human medicine. Infestation due to the roundworms Enterobius vermicularis, Ascaris lumbricoides and the hookworms, Ancylostoma duodenale and Necator americanus can all be treated effectively with pyrantel pamoate. For Enterobius vermicularis, however, a newer drug, mebendazole, is equally as effective. The advantage of these drugs in the indicated circumstances is that they can be administered in a single dose. Unfortunately, pyrantel pamoate is not a panacea and in the case of Necator it is not as effective as in the other roundworms. In that situation the use of tetrachlorethylene is preferable. For treatment of Strongyloides stercoralis, and important human parasite, because it can become disseminated and lead to fatal infections in immunoincompetent hosts, the only effective drug is thiabendazole. In treatment of Trichuris trichiura infection, mebendazole, administered over a period of 3 days, is the most effective available drug. For the roundworms inhabiting tissues--either as aberrant infections of man or as the normal part of their life cycle in man--therapy tends to be largely non-specific. For example, in visceral larva migrans, caused by the dog roundworm Toxocara canis, only palliative therapy with systemic anti-inflammatory agents and corticosteroids may be helpful. Cutaneous larva migrans, caused by the dog hookworms Ancylostoma brasiliensis and Ancylostoma caninum, is also treated primarily with symptomatic measures, but there is a suggestion that thiabendazole may kill the larvae and thus be effective. Trichinella spiralis may cause severe, even fatal infections in man, but only symptomatic therapy can be offered. Therapy for filarial infections is regrettably complicated and not completely effective. Diethylcarbamazine remains the best available drug, but in some of these infections local surgical excision may also be used. It is important to bear in mind that release of antigens from dying or dead worms may cause systemic inflammatory and allergic reactions that may require therapy with corticosteroids. Therapy for Cestodes is achieved most effectively with niclosamide, but the antimicrobial agent paromomycin has also been effective. For the aberrant cestode infections of man, such as echinococcal cysts or Taenia solium cycticerci, treatment is surgical if the affected areas are accessible. Treatment of schistosomal infections is quite toxic and, therefore, it is mandatory to determine viability of the worms before recommending therapy. If therapy is required, then Schistosoma mansoni infections are treated with stibophen and S. japonicum with antimony potassium tartrate, taking care in both of these instances to watch for the early signs of antimony toxicity; therapy of S. haematobium infections is based on administration of niridazole...

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 319991     DOI: 10.2165/00003495-197713020-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  22 in total

1.  EVALUATION OF INTRADERMAL AND SEROLOGIC TESTS IN A LARGE OUTBREAK OF TRICHINOSIS.

Authors:  G A LAMB; I G KAGAN; R SCHOLTENS; J PREIZLER
Journal:  Am J Hyg       Date:  1964-09

2.  The treatment of cases of ascariasis with piperazine citrate with observations of the effect of the drug on other helminthiases.

Authors:  C SWARTZWELDER; J H MILLER; R W SAPPENFIELD
Journal:  Am J Trop Med Hyg       Date:  1955-03       Impact factor: 2.345

3.  Clinical manifestations of clonorchiasis: a controlled study of 105 cases.

Authors:  W G STRAUSS
Journal:  Am J Trop Med Hyg       Date:  1962-09       Impact factor: 2.345

4.  An overwhelming strongyloides infection.

Authors:  H W BROWN; V P PERNA
Journal:  J Am Med Assoc       Date:  1958-11-22

5.  Studies on the chemotherapy of filariasis; some pharmacodynamic properties of l-diethylcarbamyl-4-methylpiperazine hydrochloride, hetrazan.

Authors:  B K HARNED; R W CUNNINGHAM
Journal:  J Lab Clin Med       Date:  1948-01

6.  Fatal strongyloidiasis in immunosuppressed patients.

Authors:  D T Purtilo; W M Meyers; D H Connor
Journal:  Am J Med       Date:  1974-04       Impact factor: 4.965

Review 7.  The chemotherapy of cestode infections.

Authors:  J E Keeling
Journal:  Adv Chemother       Date:  1968

8.  Surgical treatment of hydatid cysts by freezing of cyst wall and instillation of 0.5 per cent silver nitrate solution.

Authors:  F Saidi; I Nazarian
Journal:  N Engl J Med       Date:  1971-06-17       Impact factor: 91.245

9.  Treatment of trichuriasis with a new drug, mebendazole.

Authors:  S Maqbool; D Lawrence; M Katz
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

10.  Aspects of the pharmacology of a new anthelmintic: pyrantel.

Authors:  M L Aubry; P Cowell; M J Davey; S Shevde
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739

View more
  12 in total

1.  Anthelmintics. Current concepts in the treatment of helminthic infections.

Authors:  M Katz
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

2.  High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors.

Authors:  Samuel A Siles; Anand Srinivasan; Christopher G Pierce; José L Lopez-Ribot; Anand K Ramasubramanian
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

3.  The effects of piperazine on rat sympathetic neurones.

Authors:  J D Connor; A Constanti; P M Dunn; A Forward; A Nistri
Journal:  Br J Pharmacol       Date:  1981-10       Impact factor: 8.739

4.  Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide.

Authors:  Chang-Jer Wu; Jia-Tsrong Jan; Chi-Min Chen; Hsing-Pang Hsieh; Der-Ren Hwang; Hwan-Wun Liu; Chiu-Yi Liu; Hui-Wen Huang; Su-Chin Chen; Cheng-Fong Hong; Ren-Kuo Lin; Yu-Sheng Chao; John T A Hsu
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

5.  A cell-based screen reveals that the albendazole metabolite, albendazole sulfone, targets Wolbachia.

Authors:  Laura R Serbus; Frederic Landmann; Walter M Bray; Pamela M White; Jordan Ruybal; R Scott Lokey; Alain Debec; William Sullivan
Journal:  PLoS Pathog       Date:  2012-09-20       Impact factor: 6.823

6.  Drug screening identifies niclosamide as an inhibitor of breast cancer stem-like cells.

Authors:  Yu-Chi Wang; Tai-Kuang Chao; Cheng-Chang Chang; Yi-Te Yo; Mu-Hsien Yu; Hung-Cheng Lai
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

7.  The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1.

Authors:  Erica Barini; Ageo Miccoli; Federico Tinarelli; Katie Mulholland; Hachemi Kadri; Farhat Khanim; Laste Stojanovski; Kevin D Read; Kerry Burness; Julian J Blow; Youcef Mehellou; Miratul M K Muqit
Journal:  Chembiochem       Date:  2018-01-24       Impact factor: 3.164

8.  Impact of Enterobius vermicularis infection and mebendazole treatment on intestinal microbiota and host immune response.

Authors:  Chin-An Yang; Chao Liang; Chia-Li Lin; Chiung-Tzu Hsiao; Ching-Tien Peng; Hung-Chih Lin; Jan-Gowth Chang
Journal:  PLoS Negl Trop Dis       Date:  2017-09-25

Review 9.  A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers.

Authors:  Kamal Ahmed; Holly V Shaw; Alexey Koval; Vladimir L Katanaev
Journal:  Cancers (Basel)       Date:  2016-07-14       Impact factor: 6.639

10.  PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs?

Authors:  Raphael Taiwo Aruleba; Tayo Alex Adekiya; Babatunji Emmanuel Oyinloye; Priscilla Masamba; Londiwe Simphiwe Mbatha; Ashley Pretorius; Abidemi Paul Kappo
Journal:  Infect Disord Drug Targets       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.